Your search for

34 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Legal news
    11 December 2018
    Pemetrexed: Italian Court reversed the first instance decision ordering a PI on the basis of Eli Lilly's patent
    www.twobirds.com/en/news/articles/2018/italy/italian-court-reversed-the-first-instance-decision-ordering-a-pi-on-the-basis-of-eli-lillys-patent

    Diverging from the previous decision, the Court pointed out that the relevance of the file history to construe the scope of protection of a patent and then the infringement of equivalence has to be carefully and ...

  3. Legal news
    07 October 2019
    Dutch competition authority ACM publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors
    www.twobirds.com/en/news/articles/2019/netherlands/dutch-competition-authority-acm-publishes-a-sector

    The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction of biosimilars on the competition between TNF alfa inhibitors. TNF-alfa inhibitors are biological medicines that ...

  4. Legal news
    11 December 2018
    The legal basis for Belgian biobanks enters into force
    www.twobirds.com/en/news/articles/2018/belgium/the-legal-basis-for-belgian-biobanks-finally-enters-into-force

    Each Belgian biobank will have to be declared at the Federal Agency for Medicines and Health Products (FAMHP) in order to operate. It also imposes binding content for agreements on the transfer of human biological ...

  5. Legal news
    11 December 2018
    Changes afoot for Belgian manufacturers of allogeneic ATMPs
    www.twobirds.com/en/news/articles/2018/belgium/changes-afoot-for-belgian-manufacturers-of-allogeneic-atmps

    Last month, the Belgian Parliament voted in favour of a set of measures that are notably meant to clarify the regulatory landscape of the operators active in the manufacturing of Advanced Therapy Medicinal Products ...

  6. Legal news
    07 February 2019
    German Federal Patent Court denies request for preliminary grant of a compulsory license – Where do we go from here?
    www.twobirds.com/en/news/articles/2019/germany/german-federal-patent-court-denies-request-for-preliminary-grant-of-compulsory-license

    Sanofi sought a compulsory licence for the distribution of its high cholesterol drug Praluent® but this was dismissed in preliminary proceedings (docket no: 3 LiQ 1/18).

  7. Legal news
    04 November 2019
    Are German Courts the “Spoilsport” of the “Divisional Game” when it comes to Preliminary Injunction Requests?
    www.twobirds.com/en/news/articles/2019/germany/are-germany-courts-the-spoilsport-of-the-divisional-game-when-it-comes-to

    If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...

  8. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...